Analyzing...
Loading company...
Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹4,410 Cr service revenue.
Employee costs at 24.9% of revenue — primary cost driver.
“five to seven is a reasonable number”
“EBITDA, excluding Noida, grew by 11% year on year to INR 2,814 million with healthy margins of 25.”
“hope so, that we've seen the peak of the losses.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 14.1%▲ | 9.0% |
| ROCE | 15.0%▲ | 10.4% |
| Net Margin | 12.3%▲ | 8.5% |
| EBITDA Margin | 22.6%▲ | 20.6% |
| Debt To Equity | 0.30x▲ | 0.16x |
| Rev Growth 3yr | 17.8%▲ | 14.4% |
| EPS Growth 3yr | 19.4%▲ | 9.9% |
| Employee Cost Ratio | 24.90x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | ₹4,683 Cr +26.8% | ₹3,692 Cr +12.7% | ₹3,275 Cr +21.6% | ₹2,694 Cr |
| Other Income | ₹100 Cr +27.0% | ₹79 Cr +5.9% | ₹75 Cr +15.0% | ₹65 Cr |
| Total Income | ₹4,784 Cr +26.8% | ₹3,771 Cr +12.6% | ₹3,350 Cr +21.4% | ₹2,759 Cr |
| COGS | ₹1,052 Cr +19.6% | ₹880 Cr +15.8% | ₹759 Cr +21.4% | ₹625 Cr |
| ₹4,043 Cr +31.5% | ₹3,074 Cr +12.9% | ₹2,723 Cr +17.9% | ₹2,310 Cr | |
| Profit Before Tax | ₹720 Cr +11.3% | ₹647 Cr +3.2% | ₹627 Cr +39.6% | ₹449 Cr |
| Exceptional Items | (₹21 Cr) +58.7% | (₹50 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| ₹168 Cr +1.1% | ₹166 Cr +11.3% | ₹149 Cr +21.0% | ₹123 Cr | |
| Net Profit | ₹552 Cr +14.8% | ₹481 Cr +0.7% | ₹478 Cr +46.6% | ₹326 Cr |
| Profit (Owners) | ₹556 Cr +15.5% | ₹481 Cr +0.7% | ₹478 Cr +46.6% | ₹326 Cr |
| Minority Interest | (₹4 Cr) | (₹0.12 Cr) +11.2% | (₹0.13 Cr) | ₹0.00 Cr |
| Other Comprehensive Income | (₹2 Cr) -161.3% | (₹0.67 Cr) +28.6% | (₹0.94 Cr) ↓ Decline | ₹1 Cr |
| EPS | ₹20.69 | ₹17.92 | ₹17.81 | ₹12.16 |
| Diluted Shares | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Global Health Limited has informed the Exchange about Link of Recording
Global Health Limited has informed the Exchange about Copy of Newspaper Publication
Global Health Limited has informed the Exchange about Investor Presentation
Global Health Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "Press release for the Results of First Quater ended June 30, 2026".
Global Health Limited has informed the Exchange regarding 'Global Health Limited has informed the exchage about date for payment of Dividend'.
Global Health Limited has informed the Exchange about Capacity addition
Global Health Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Aug-2026.
Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on July 30, 2026.
Global Health Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Global Health Limited has informed the Exchange regarding Grant of 20000 Options.
Global Health Limited has informed the Exchange about Schedule of meet
Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Global Health Limited has informed the Exchange about Certificates under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2026.
Global Health Limited has informed the Exchange about Schedule of meet.
Global Health Limited has informed the Exchange about Schedule of meet.